daniel's blog

Each year, ATA hosts an auction of celebrity memorabilia to raise awareness, and more importantly, to raise funds supporting our mission: curing tinnitus through the development of resources that advance tinnitus research. These auctions are held at times when ATA has a sufficient number of items to generate interest from the broader community.

Neuromonics, Inc., the maker and distributor of the Oasis, an FDA-cleared, patented and clinically proven medical device designed for long-term significant relief of tinnitus, has received a $700,000 contract from the U.S. Army to study the effects and use of the Neuromonics Tinnitus Treatment (NTT) in military environments.

Preliminary results from Auris Medical's phase IIB study show that the local treatment with AM-101 was very well tolerated, and in particular that it had no negative impact on hearing.

ATA Scientific Advisory Committee member Jim Henry's study on a new way to view and evaluate the daily effects of chronic tinnitus, via personal digital assistant, was recently published.

Ryan Adams didn't write a song or even play a guitar for a year and a half. He was trying to recover his hearing, diminished by tinnitus and Ménière's disease, an inner-ear disorder that also causes dizziness and pain. "I just heard this sort of sound fog. Like a radio station had gone off the air," he recalls.

A new study involving ATA Board Member Carol Bauer, M.D., and recent Scientific Advisory Committee member Tom Brozoski, Ph.D., showed that bilateral dorsal DCN (dorsal cochlear nucleus) lesions made before high-level noise exposure prevented the development of tinnitus.

Otonomy, Inc., a clinical stage biopharmaceutical company, presented study data demonstrating that both the 3 mg and 12 mg OTO-104 doses were associated with improvement in tinnitus as measured by the Tinnitus Handicap Inventory (THI-25).

The Jack Vernon Walk to Silence Tinnitus is the American Tinnitus Association's signature fundraising event. The Walk honors the lifelong work of ATA's founder, Jack A. Vernon, Ph.D., and raises important funds for tinnitus research. 100% of the proceeds will be utilized to fund ATA's research grants. Every $50,000 raised by ATA allows us to award one research grant! Please see below for details on how to sign up for the Walk or support a walker.

Like most tinnitus and hyperacusis sufferers, getting one's life back is often a tough road and requires a system of support and understanding. When musician and teacher Joel Styzens could not find a tinnitus support group in Chicago he worked with ATA to start one.

Scottish singer-songwriter and guitarist KT Tunstall, renowned for her live performances and hit song "Hold On", tells the Belfast Telegraph about her tinnitus and efforts to raise hearing loss awareness.